Literature DB >> 6752030

Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria.

F Clas, M Loos.   

Abstract

Killing of Salmonella minnesota and Salmonella typhimurium S and R strains in serum of nonimmune humans and guinea pigs was drastically reduced in the selective absence of C1q, C1r, Ca2+, C4, or C2, the components of the classical complement pathway. Binding of C1 and C1q to the S form and six different core-deficient R mutant strains became stronger the shorter the lipopolysaccharide molecule. C1 and C1q had, under physiological conditions, no affinity to the serum-resistant S forms, whereas these components were bound by the serum-sensitive R forms with high affinity. However, a mixture of the individual complement components C1-C9, which rapidly lysed sensitized erythrocytes, did not kill the serum-sensitive bacteria. Isolated C1 bound to these bacteria cleaved fluid-phase C4 but did not convert C2. C2 turnover could be detected only when serum was used as a source of C1 or C4, indicating that an additional serum component is necessary for the antibody-independent bactericidal effect. Functional tests indicated that this factor is a euglobulin which mediates binding of C4 to the bacteria even in the absence of C1 or after treatment with EDTA. Binding of C4 followed by the generation of C4b sites as acceptors for C2 was a prerequisite for the killing of the bacteria. The factor could not be replaced by immunoglobulin G or immunoglobulin M, nor was it blocked by preincubation with anti-immunoglobulin G or anti-immunoglobulin M.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752030      PMCID: PMC347628          DOI: 10.1128/iai.37.3.935-939.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Differences in activation of human and guinea pig complement by retroviruses.

Authors:  R M Bartholomew; A F Esser
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

2.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  Humoral bactericidal systems: antibacterial potential of serum from young animals.

Authors:  R C Skarnes
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

4.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  Complement-mediated bactericidal system: evidence for a new pathway of complement action.

Authors:  S C Moreau; R C Skarnes
Journal:  Science       Date:  1975-10-17       Impact factor: 47.728

6.  Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants.

Authors:  J Smit; Y Kamio; H Nikaido
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

7.  Interactions between mycoplasma pneumoniae and the first components of complement.

Authors:  W Bredt; B Wellek; H Brunner; M Loos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Antibody-independent interaction of the first component of complement with Gram-negative bacteria.

Authors:  M Loos; B Wellek; R Thesen; W Opferkuch
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

9.  Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).

Authors:  A B Wilson; S Prichard-Thomas; P J Lachmann; R R Coombs
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

10.  Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.

Authors:  F Clas; M Loos
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

View more
  5 in total

1.  Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.

Authors:  R P Darveau; J Blake; C L Seachord; W L Cosand; M D Cunningham; L Cassiano-Clough; G Maloney
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 2.  Activation of the complement system by pathogenic fungi.

Authors:  T R Kozel
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

3.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.

Authors:  G Pluschke; M Achtman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.

Authors:  G Pluschke; J Mayden; M Achtman; R P Levine
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.